GLAXOSMITHKLINE TYSON TO LEAVE..

GlaxoSmithKline Tyson To Leave; Pulman Appointed President, Global Manufacturing & Supply GlaxoSmithKline plc [GSK] announced today that Tim Tyson, currently President, Global Manufacturing & Supply, will leave GSK to take up a new position as President and Chief Operating Officer for ICN Pharmaceuticals Inc., a research-based specialty pharmaceuticals company, based in Costa Mesa, California. This becomes effective 1 December 2002. Dr. David Pulman, currently Senior Vice President - Strategy, Logistics & North American Supply, Global Manufacturing & Supply, GlaxoSmithKline, will be named President, Global Manufacturing & Supply, and will report to Robert Ingram, until Mr. Ingram's retirement on 31 December 2002. Subsequently he will report to David Stout, who assumes the role of President, Pharmaceuticals Operations, from January 2003. Dr. Pulman will be based in Research Triangle Park, North Carolina, US. Jean-Pierre Garnier, CEO for GlaxoSmithKline said: "Tim has done a great job in integrating two large global manufacturing networks and maintaining very high quality supply of our pharmaceutical products. I would like to thank Tim for his outstanding contribution to GSK. We are sorry to lose him and wish Tim the very best of luck in his new role. "David is currently a member of GSK's Global Manufacturing & Supply Executive Team, responsible for the North American supply network, manufacturing strategy and logistics. David brings a wealth of expertise to the role, having held many positions in the group's manufacturing operations. We welcome David to GSK's Corporate Executive Team and look forward to his contribution." Robert Ingram, Chief Operating Officer and President Pharmaceutical Operations, commented: "I have worked closely with Tim for twelve years and I admire his outstanding leadership abilities. While we are sorry to lose him, we are proud and happy for the opportunity he has earned. Tim leaves behind a legacy of high principals, a track record of continuous high achievement and a great team. We are extremely fortunate to have in David Pullman an excellent leader who can carry on and build upon Tim's accomplishments as he now assumes the global leadership of this critical function." Tim Tyson said: "I have been with GSK and its predecessors for more than fourteen years, and very much enjoyed my time with the company, most recently in leading GSK's Global Manufacturing & Supply operations, where I have worked with a terrific team of dedicated professionals. Although I will miss GSK, I now feel that the time is right to take on the role of running a company's global commercial operation. My new role at ICN Pharmaceuticals Inc., is a great opportunity for me in that respect. I am proud of all that the GMS team has accomplished and confident that David will provide the necessary leadership for GMS." GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. Editor's Notes Biography: Tim Tyson, President, Global Manufacturing & Supply, GlaxoSmithKline Tim Tyson took up the position of President, Global Manufacturing & Supply, GlaxoSmithKline in January 2001. He is a member of the Corporate Executive Team. He held the position of senior vice president and director, Worldwide Manufacturing & Supply, Glaxo Wellcome, from June 1998. Previously he was Vice President and General Manager of Business Operations for Glaxo Wellcome Inc. with 22 regional business units in the US and responsibility for the US sales force and Vice President and General Manager of Marketing for Glaxo Wellcome Inc. Tim joined Glaxo Inc., in August 1988. He has a BSc in Mechanical Engineering from the US Military Academy at West Point and a Masters in Business and Public Administration from Jacksonville State University. Biography: Dr. David Pulman, Senior Vice President - Strategy, Logistics & North American Supply, Global Manufacturing & Supply, GlaxoSmithKline David is currently responsible for the North American supply network, Global Logistics and Strategy, and for the team leading and monitoring the Global Supply Network programme. Formerly he led manufacturing and supply operations in Europe. David joined Glaxo in 1978 and has held a number of positions within GlaxoChem and in UK and international operations. He has a PhD in microbiology. Enquiries: UK Media enquiries: Martin Sutton (020) 8047 5502 Alan Chandler (020) 8047 5502 Siobhán Lavelle (020) 8047 5502 US Media enquiries: Nancy Pekarek (215) 751 7709 Mary Anne Rhyne (919) 483 2839 Patricia Seif (215) 751 7709 European Analyst/Investor enquiries: Duncan Learmouth (020) 8047 5540 Philip Thomson (020) 8047 5543 US Analyst/ Investor enquiries: Frank Murdolo (215) 751 7002 Tom Curry (215) 751 5419 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/11/07/20021107BIT00630/wkr0001.doc http://www.waymaker.net/bitonline/2002/11/07/20021107BIT00630/wkr0002.pdf